PSIL
PSIL
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 RLMD | Relmada Therapeutics, Inc. | 10.27% | 295.87K | $2.18M |
 ATAI | Atai Beckley N.V | 10.12% | 567.59K | $2.15M |
 DFTX | Definium Therapeutics, Inc. | 9.56% | 91.30K | $2.03M |
 CMPS | COMPASS Pathways plc | 6.70% | 246.74K | $1.42M |
 DRUG | Bright Minds Biosciences Inc. | 5.41% | 13.51K | $1.15M |
 ANRO | Alto Neuroscience, Inc. | 5.33% | 44.02K | $1.13M |
 GHRS | GH Research PLC | 5.15% | 67.03K | $1.10M |
 HELP | Cybin Inc. Common Stock | 5.00% | 195.60K | $1.06M |
 NRXP | NRx Pharmaceuticals, Inc. | 4.72% | 440.47K | $1.00M |
 ABBV | AbbVie Inc. | 4.53% | 4.67K | $963.18K |
 JNJ | Johnson & Johnson | 4.45% | 3.98K | $946.60K |
 ALKS | Alkermes plc | 4.38% | 27.57K | $930.45K |
 NBIX | Neurocrine Biosciences, Inc. | 4.26% | 7.17K | $905.71K |
 STIM | Neuronetics, Inc. | 4.21% | 643.19K | $894.04K |
 SUPN | Supernus Pharmaceuticals, Inc. | 4.10% | 17.45K | $871.78K |
 NEUP | Neuphoria Therapeutics Inc. | 3.33% | 155.37K | $708.47K |
 QNTM | Quantum BioPharma Ltd. | 2.03% | 128.59K | $431.42K |
 KTTA | Pasithea Therapeutics Corp. | 1.98% | 557.51K | $420.92K |
 SILO | Silo Pharma, Inc. | 1.41% | 693.97K | $299.03K |
 IXHL | Incannex Healthcare Limited | 1.01% | 735.10K | $206.93K |
SECTOR HOLDINGS
Healthcare
Cash & OthersASSET ALLOCATION BY REGION
United States
Ireland
Canada
United Kingdom
AustraliaSECTOR HOLDINGS
Healthcare Cash & OthersASSET ALLOCATION BY REGION
United States Ireland Canada United Kingdom AustraliaHoldings (Top 20)
RLMD
Relmada Therapeutics, Inc.
ATAI
Atai Beckley N.V
DFTX
Definium Therapeutics, Inc.
CMPS
COMPASS Pathways plc
DRUG
Bright Minds Biosciences Inc.
ANRO
Alto Neuroscience, Inc.
GHRS
GH Research PLC
HELP
Cybin Inc. Common Stock
NRXP
NRx Pharmaceuticals, Inc.
ABBV
AbbVie Inc.
JNJ
Johnson & Johnson
ALKS
Alkermes plc
NBIX
Neurocrine Biosciences, Inc.
STIM
Neuronetics, Inc.
SUPN
Supernus Pharmaceuticals, Inc.
NEUP
Neuphoria Therapeutics Inc.
QNTM
Quantum BioPharma Ltd.
KTTA
Pasithea Therapeutics Corp.
SILO
Silo Pharma, Inc.
IXHL
Incannex Healthcare Limited